Our assay directly measures hydrogen ______ levels. Follistatin retains its antioxidant effect even when denatured. True/False What does the abbreviation 'SHR' stand for? _____________ FST was administered every ______ day. Which normotensive strain served as our control? _____________ Enhanced NO bioavailability indicates improved ______. What is the endogenous protein we studied that antagonizes activin? _____________ The fluorescent product produced in the AmplexRed assay is called ______. FST’s antioxidant effect is lost if it is ______. Follistatin treatment reduced blood pressure by approximately ______ mmHg. Neutralizing antibodies targeted activin A and ______. Follistatin must maintain its proper ______ to be functional. Follistatin is known to neutralize signaling by ______. Which type of assay is used to evaluate NO levels in our study: fluorometric or colorimetric? _____________ Our study shows that blocking activin signaling reduces ______ production. In our study, follistatin was administered to SHRs over a period of ______ weeks. Follistatin treatment induces ______ of PVAT, a phenotype associated with improved vascular function. Which hypertensive animal model did we use? ___________ Follistatin increases the expression of ______, which is critical for nitric oxide production. Hypertension is defined by sustained blood pressure above ____ mmHg. Which protein marker indicates a brown adipose phenotype in PVAT? _____________ What assay did we use to quantify hydrogen peroxide? _____________ "In our experiments, the reduction in oxidative stress was measured as a decrease in the fold change of ______. FST lowers ROS levels, as indicated by a decrease in ______ levels. Our assay directly measures hydrogen ______ levels. Follistatin retains its antioxidant effect even when denatured. True/False What does the abbreviation 'SHR' stand for? _____________ FST was administered every ______ day. Which normotensive strain served as our control? _____________ Enhanced NO bioavailability indicates improved ______. What is the endogenous protein we studied that antagonizes activin? _____________ The fluorescent product produced in the AmplexRed assay is called ______. FST’s antioxidant effect is lost if it is ______. Follistatin treatment reduced blood pressure by approximately ______ mmHg. Neutralizing antibodies targeted activin A and ______. Follistatin must maintain its proper ______ to be functional. Follistatin is known to neutralize signaling by ______. Which type of assay is used to evaluate NO levels in our study: fluorometric or colorimetric? _____________ Our study shows that blocking activin signaling reduces ______ production. In our study, follistatin was administered to SHRs over a period of ______ weeks. Follistatin treatment induces ______ of PVAT, a phenotype associated with improved vascular function. Which hypertensive animal model did we use? ___________ Follistatin increases the expression of ______, which is critical for nitric oxide production. Hypertension is defined by sustained blood pressure above ____ mmHg. Which protein marker indicates a brown adipose phenotype in PVAT? _____________ What assay did we use to quantify hydrogen peroxide? _____________ "In our experiments, the reduction in oxidative stress was measured as a decrease in the fold change of ______. FST lowers ROS levels, as indicated by a decrease in ______ levels.
(Print)
Our assay directly measures hydrogen ______ levels.
Follistatin retains its antioxidant effect even when denatured.
True/False
What does the abbreviation 'SHR' stand for?
_____________
FST was administered every ______ day.
Which normotensive strain served as our control?
_____________
Enhanced NO bioavailability indicates improved ______.
What is the endogenous protein we studied that antagonizes activin?
_____________
The fluorescent product produced in the AmplexRed assay is called ______.
FST’s antioxidant effect is lost if it is ______.
Follistatin treatment reduced blood pressure by approximately ______ mmHg.
Neutralizing antibodies targeted activin A and ______.
Follistatin must maintain its proper ______ to be functional.
Follistatin is known to neutralize signaling by ______.
Which type of assay is used to evaluate NO levels in our study: fluorometric or colorimetric?
_____________
Our study shows that blocking activin signaling reduces ______ production.
In our study, follistatin was administered to SHRs over a period of ______ weeks.
Follistatin treatment induces ______ of PVAT, a phenotype associated with improved vascular function.
Which hypertensive animal model did we use?
___________
Follistatin increases the expression of ______, which is critical for nitric oxide production.
Hypertension is defined by sustained blood pressure above ____ mmHg.
Which protein marker indicates a brown adipose phenotype in PVAT?
_____________
What assay did we use to quantify hydrogen peroxide?
_____________
"In our experiments, the reduction in oxidative stress was measured as a decrease in the fold change of ______.
FST lowers ROS levels, as indicated by a decrease in ______ levels.
